Mega Genomics Limited (HKG:6667)
Hong Kong · Delayed Price · Currency is HKD 6.99
+0.03 (0.43%)
At close: Mar 6, 2026
Mega Genomics Market Cap
Mega Genomics has a market cap or net worth of 1.57 billion as of March 6, 2026. Its market cap has decreased by -22.09% in one year.
Market Cap
1.57B
Enterprise Value
1.11B
Revenue
151.45M
Ranking
n/a
PE Ratio
38.56
Stock Price
6.99
Market Cap Chart
Since June 22, 2022, Mega Genomics's market cap has decreased from 4.31B to 1.57B, a decrease of -63.59%. That is a compound annual growth rate of -23.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.57B | -37.41% |
| Dec 31, 2024 | 2.50B | 2.28% |
| Dec 29, 2023 | 2.45B | -21.25% |
| Dec 30, 2022 | 3.11B | -27.78% |
| Jun 22, 2022 | 4.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi XDC Cayman | 70.45B |
| Guanze Medical Information Industry (Holding) | 3.60B |
| Adicon Holdings | 3.29B |
| Kindstar Globalgene Technology | 1.14B |
| Biosino Bio-Technology and Science Incorporation | 764.05M |
| China Biotech Services Holdings | 683.01M |
| Yunkang Group | 409.74M |
| King International Investment | 198.00M |